文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Impact of first and second/third wave of COVID-19 pandemic on post-acute cardiovascular outcomes in Lombardy.

作者信息

Ojeda-Fernández Luisa, Baviera Marta, Foresta Andreana, Tettamanti Mauro, Zambon Antonella, Macaluso Giulia, Schena Simone, Leoni Olivia, Fortino Ida, Roncaglioni Maria Carla, Parati Gianfranco

机构信息

Laboratory of Cardiovascular Prevention, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Laboratory of Geriatric Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

出版信息

Front Cardiovasc Med. 2023 Sep 12;10:1244002. doi: 10.3389/fcvm.2023.1244002. eCollection 2023.


DOI:10.3389/fcvm.2023.1244002
PMID:37781303
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10536134/
Abstract

BACKGROUND: COVID-19 has been associated with a higher risk of post-acute complications. Our aim was to analyze and compare post-acute cardiovascular complications of COVID-19 survivors of the first and second/third pandemic waves in Lombardy, in both hospitalized and non-hospitalized COVID-19 patients. METHODS AND RESULTS: We included adults aged ≥40 years infected during the first and second/third waves of COVID-19 pandemic. The follow-up initiated 30 days after COVID-19 diagnosis and continued up to 9 months. Hazard ratios (HRs) and 95% confidence intervals (CIs) of the post-acute cardiovascular outcomes were calculated against an inverse probability treatment weighted control group. Subgroup analysis were performed by age classes, sex, previous cardiovascular disease and stratified by COVID-19 hospitalization status to explore the impact of COVID-19 severity on outcomes. Compared to the control group, COVID-19 patients had an increased risk of hospitalization for any cardiovascular complications (HR 1st wave 1.53 95% CI: 1.38-1.69; HR 2nd/3rd wave 1.25 95% CI: 1.19-1.31) and for individual cardiovascular outcomes, although HRs were higher in COVID-19 group from the 1st pandemic wave. The results were confirmed in the subgroup analyses. Of note, the risk for any cardiovascular disease was also evident even among individuals who were not hospitalized during the acute phase of the infection. CONCLUSION: Our results provide evidence that COVID-19 is a risk factor for post-acute cardiovascular complications among different pandemic waves regardless of COVID-19 severity, age, sex and a history of cardiovascular diseases. Care strategies of people with COVID-19 should include cardiac monitoring.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb27/10536134/d5de05a72b5d/fcvm-10-1244002-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb27/10536134/b9d9d673de4f/fcvm-10-1244002-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb27/10536134/40ce1bdba75c/fcvm-10-1244002-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb27/10536134/d5de05a72b5d/fcvm-10-1244002-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb27/10536134/b9d9d673de4f/fcvm-10-1244002-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb27/10536134/40ce1bdba75c/fcvm-10-1244002-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb27/10536134/d5de05a72b5d/fcvm-10-1244002-g003.jpg

相似文献

[1]
Impact of first and second/third wave of COVID-19 pandemic on post-acute cardiovascular outcomes in Lombardy.

Front Cardiovasc Med. 2023-9-12

[2]
Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: A retrospective cohort study from the TriNetX US collaborative networks.

EClinicalMedicine. 2022-11

[3]
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.

Cochrane Database Syst Rev. 2022-2-1

[4]
Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition.

JAMA Intern Med. 2023-6-1

[5]
Analysis of the impact of the SARS-CoV-2 infection on the pediatric population hospitalized during the pandemic in the Greater Paris University Hospitals.

Front Pediatr. 2023-2-27

[6]
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.

Trials. 2020-10-28

[7]
The impact of shifting demographics, variants of concern and vaccination on outcomes during the first 3 COVID-19 waves in Alberta and Ontario: a retrospective cohort study.

CMAJ Open. 2022

[8]
Risks and burdens of incident dyslipidaemia in long COVID: a cohort study.

Lancet Diabetes Endocrinol. 2023-2

[9]
Pregnancy Outcomes in Women With SARS-CoV-2 Infection During the First and Second Waves of the COVID-19 Pandemic in a Tertiary Care Hospital in Ayodhya, Uttar Pradesh, India: A Comparative Study.

Cureus. 2023-2-14

[10]
Pulmonary Functional Outcomes at 3 Months in Critical COVID-19 Survivors Hospitalized during the First, Second, and Third Pandemic Waves.

J Clin Med. 2023-5-27

本文引用的文献

[1]
Cardiovascular risk and the COVID-19 pandemic: A retrospective observational study in a population of healthcare professionals.

Nutr Metab Cardiovasc Dis. 2023-7

[2]
Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank.

Heart. 2022-12-22

[3]
Long Covid: where we stand and challenges ahead.

Cell Death Differ. 2022-10

[4]
The cross-talk of lung and heart complications in COVID-19: Endothelial cells dysfunction, thrombosis, and treatment.

Front Cardiovasc Med. 2022-8-5

[5]
Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: A retrospective cohort study from the TriNetX US collaborative networks.

EClinicalMedicine. 2022-11

[6]
When Outcomes Diverge: Age and Cardiovascular Risk as Determinants of Mortality and ICU Admission in COVID-19.

J Clin Med. 2022-7-15

[7]
Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study.

Lancet Infect Dis. 2022-8

[8]
Cardiovascular complications in the Post-Acute COVID-19 syndrome (PACS).

Int J Cardiol Heart Vasc. 2022-3-28

[9]
Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus.

Eur Heart J. 2022-3-14

[10]
Predictors of Mortality and Cardiovascular Outcome at 6 Months after Hospitalization for COVID-19.

J Clin Med. 2022-1-29

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索